Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Flutamide reduces hair growth better but has more side effects.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Hair loss in women not always linked to increased oil production; other factors may be involved.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Finasteride doesn't affect hormone levels in normal men.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.